Revive Toric RWE Study

Starting soon

Conditions studied: Astigmatism

In brief

This is a post-market observational clinical investigation. The objective of this observational study is to evaluate the visual performance and HCP satisfaction of REVIVE samfilcon B custom toric contact lenses.

Key facts

Study ID

NCT06785194

Run by

Bausch & Lomb Incorporated

People needed

30

Starts

2026-05-01

Expected to finish

2026-07-01

Last updated by the study team

2025-11-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Be 18 years or older on the date the ICF is signed
• Have the capacity to read, understand, and provide written voluntary informed consent
• Have physiologically normal anterior segments not exhibiting clinically significant biomicroscopy findings
• Have no active ocular disease or allergic conjunctivitis
• Not be using any topical ocular medications
• Be willing and able to follow instructions
• Have signed a statement of informed consent
• Be an experienced soft contact lens wearer (have previously used soft contact lenses)
• Meet the indications per the Instructions for Use (IFU) and have a suitable prescription for treatment with the device

You may not qualify if…

• Is participating in another research study
• Is considered by the Investigator to not be a suitable candidate for participation
• Is not eligible for treatment with the study lens per the IFU (contraindicated)
• Has had previous ocular surgery
• Is taking/using ocular, systemic, or topical medications that, in the Investigator's opinion, could potentially affect ocular physiology or lens/solution performance

Where it is running

• Site 101 — Orange Park, Florida, United States
• Site 102 — Orange Park, Florida, United States
• Site 103 — Canton, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.